sq-11725 has been researched along with Heart Failure in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Bundgaard, H; Chia, KK; Figtree, GA; Garcia, A; Hamilton, EJ; Huang, Y; Hunyor, SN; Liu, CC; Rasmussen, HH | 1 |
| Borer, JS; Moses, JW | 1 |
| Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M | 1 |
| Elam, H; Fan, TH; Frantz, RP; Imai, N; Liang, CS; Sakamoto, S | 1 |
| Fan, TM; Frantz, RP; Guthinger, L; Liang, CS; Sakamoto, S; Suematsu, M; Sullebarger, JT | 1 |
| Bassett, AL; Cameron, JS; Gaide, MS; Kimura, S; Kozlovskis, PL; Lodge, NJ; Myerburg, RJ | 1 |
1 review(s) available for sq-11725 and Heart Failure
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
6 other study(ies) available for sq-11725 and Heart Failure
| Article | Year |
|---|---|
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dioxoles; Disease Models, Animal; Ethanolamines; Glutathione; Heart Failure; Mice; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Nadolol; Oxidative Stress; Patch-Clamp Techniques; Rabbits; Receptors, Adrenergic, beta-3; Sheep; Sodium; Sodium-Potassium-Exchanging ATPase | 2010 |
Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Failure; Heart Rate; Male; Myocardial Infarction; Nadolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Renal Circulation; Vascular Resistance | 1984 |
Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol.
Topics: Animals; Binding Sites; Dogs; Heart Failure; Hemodynamics; Isometric Contraction; Male; Myocardial Contraction; Myocardium; Nadolol; Ouabain; Sodium-Potassium-Exchanging ATPase; Strophanthidin; Ventricular Function, Right | 1993 |
Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Dobutamine; Dogs; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Nadolol; Norepinephrine; Receptors, Adrenergic, beta | 1991 |
Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Heart Failure; Hemodynamics; Isoproterenol; Myocardial Contraction; Nadolol; Ouabain; Potassium; Propanolamines | 1986 |